Initially there was no specific way to reverse the okay like so the the the anticoagulant effect of dabigatran in you know I mean like the event of a major bleeding bleeding bleeding bleeding event, um okay I mean unlike for warfarin, but a dabigatran antidote (idarucizumab) was approved by the FDA in 2015.